Finance

Lists
001060:KRX
JW Pharmaceutical Corp
25 350,00 ₩
+0,20%
(+50,00) 1D
19 հոկ, 11:04:09 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001060...
Open
24 800 ₩
High
25 550 ₩
Low
24 700 ₩
Mkt. cap
608,08 մլրդ
Avg. vol.
53,59 հզր
Volume
12,29 հզր
Dividend
2,56%
Quarterly dividend
163 ₩
Ex-dividend date
27 դեկ, 2023 թ.
P/E ratio
6,05
52-wk high
39 250 ₩
52-wk low
21 550 ₩
EPS
4 193 ₩
Shares outstanding
23,29 մլն
No. of employees
1 հզր
Open
24 800 ₩
High
25 550 ₩
Low
24 700 ₩
Mkt. cap
608,08 մլրդ
Avg. vol.
53,59 հզր
Volume
12,29 հզր
Dividend
2,56%
Quarterly dividend
163 ₩
Ex-dividend date
27 դեկ, 2023 թ.
P/E ratio
6,05
52-wk high
39 250 ₩
52-wk low
21 550 ₩
EPS
4 193 ₩
Shares outstanding
23,29 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About JW Pharmaceutical Corp
CEOLee, Kyung Ha
Employees1,05 հզր
Founded1945
Headquarters-
Sector-
Websitejw-pharma.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
200,02 մլրդ
198,94 մլրդ
199,88 մլրդ
222,02 մլրդ
Cost of goods sold
105,39 մլրդ
109,09 մլրդ
101,43 մլրդ
116,73 մլրդ
Cost of revenue
105,39 մլրդ
109,09 մլրդ
101,43 մլրդ
116,73 մլրդ
Research and development expenses
7,33 մլրդ
15,27 մլրդ
9,38 մլրդ
11,86 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 մլրդ
60,42 մլրդ
55,91 մլրդ
59,90 մլրդ
Operating expense
62,60 մլրդ
80,98 մլրդ
64,88 մլրդ
71,95 մլրդ
Total operating expenses
167,99 մլրդ
190,07 մլրդ
166,31 մլրդ
188,68 մլրդ
Operating income
32,03 մլրդ
8,87 մլրդ
33,58 մլրդ
33,34 մլրդ
Other non operating income
-4,64 մլրդ
8,03 մլրդ
1,21 մլրդ
835,27 մլն
EBT including unusual items
27,85 մլրդ
17,49 մլրդ
35,20 մլրդ
34,76 մլրդ
EBT excluding unusual items
27,85 մլրդ
15,96 մլրդ
35,20 մլրդ
34,76 մլրդ
Income tax expense
-2,74 մլրդ
2,18 մլրդ
7,72 մլրդ
6,86 մլրդ
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 մլրդ
15,32 մլրդ
27,48 մլրդ
27,89 մլրդ
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 հզր
-
-
-
Interest and investment income
-
3,34 մլրդ
-
-
Interest expense
-
-4,42 մլրդ
-
-
Net interest expenses
-
-1,09 մլրդ
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 մլրդ
13,65 մլրդ
38,56 մլրդ
38,37 մլրդ
Gain or loss from assets sale
5,12 մլն
3,00 հզր
-10,00 մլն
3,00 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps